Cargando…
Can dietary flavonoids be useful in the personalized treatment of colorectal cancer?
Activating mutations in the oncogenes KRAS, BRAF and PI3K define molecular colorectal cancer (CRC) subtypes because they play key roles in promoting CRC development and in determining the efficacy of chemotherapeutic agents such as 5-fluorouracil and anti-epidermal growth factor receptor monoclonal...
Autor principal: | Pereira-Wilson, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244991/ https://www.ncbi.nlm.nih.gov/pubmed/35949218 http://dx.doi.org/10.4251/wjgo.v14.i6.1115 |
Ejemplares similares
-
Predicting systemic spread in early colorectal cancer: Can we do better?
por: Brockmoeller, Scarlet Fiona, et al.
Publicado: (2019) -
Nanotechnology for colorectal cancer detection and treatment
por: Gogoi, Purnima, et al.
Publicado: (2022) -
Systemic treatment for metastatic colorectal cancer
por: Leowattana, Wattana, et al.
Publicado: (2023) -
Application of Newcastle disease virus in the treatment of colorectal cancer
por: Song, Hui, et al.
Publicado: (2019) -
Micelles as potential drug delivery systems for colorectal cancer treatment
por: Fatfat, Zaynab, et al.
Publicado: (2022)